Umbilical cord blood transplantation for thalassemia major

Hematology/Oncology Clinics of North America

Volumn 24, Issue 6, 2010, Pages 1165-1177

  Kanathezhath, Bindu ^a   Walters, Mark C ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

Graft versus host disease; Hematopoietic cell transplantation; Thalassemia major; Umbilical cord blood

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; METHOTREXATE; THIOTEPA; THYMOCYTE ANTIBODY;

CORD BLOOD STEM CELL TRANSPLANTATION; DONOR; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; REVIEW; SIBLING; THALASSEMIA MAJOR;

BETA-THALASSEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; HUMANS; SIBLINGS; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 78249251141     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2010.08.006     Document Type: Review

References (41)

1. Thomas E.D., Buckner C.D., Sanders J.E., et al. Marrow transplantation for thalassaemia. Lancet 1982, 2(8292):227-229.
2. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989, 321(17):1174-1178.
3. Rocha V., Gluckman E. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol 2009, 147(2):262-274.
4. Cohen G., Carter S.L., Weinberg K.I., et al. Antigen-specific T-lymphocyte function after cord blood transplantation. Biol Blood Marrow Transplant 2006, 12(12):1335-1342.
5. Rocha V., Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 2008, 41(2):207-214.
6. Michel G., Rocha V., Chevret S., et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group Analysis. Blood 2003, 102(13):4290-4297.
7. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord transplant group and the European blood and marrow transplantation group. N Engl J Med 1997, 337(6):373-381.
8. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998, 339(22):1565-1577.
9. Wagner J.E., Barker J.N., DeFor T.E., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002, 100(5):1611-1618.
10. Rocha V., Sanz G., Gluckman E. Umbilical cord blood transplantation. Curr Opin Hematol 2004, 11(6):375-385.
11. Gluckman E., Rocha V., Arcese W., et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004, 32(4):397-407.
12. Gluckman E., Rocha V., Ionescu I., et al. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007, 13(9):1073-1082.
13. Walters M.C., Quirolo L., Trachtenberg E.T., et al. Sibling donor cord blood transplantation for thalassemia major: experience of the sibling donor cord blood program. Ann N Y Acad Sci 2005, 1054:206-213.
14. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007, 110(8):3064-3070.
15. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105(3):1343-1347.
16. Rocha V., Mohty M., Gluckman E., et al. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Curr Opin Oncol 2009, 21(Suppl 1):S31-S34.
17. Pinto F.O., Roberts I. Cord blood stem cell transplantation for haemoglobinopathies. Br J Haematol 2008, 141(3):309-324.
18. Locatelli F., Rocha V., Reed W., et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003, 101(6):2137-2143.
19. Kabbara N., Locatelli F., Rocha V., et al. A multicentric comparative analysis of outcomes of HLA-identical related cord blood and bone marrow transplantation in patients with beta-thalassemia or sickle cell disease. Biol Blood Marrow Transplant 2008, 14(2):3-4.
20. Bernaudin F., Socie G., Kuentz M., et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007, 110(7):2749-2756.
21. Soni S., Cowman M.J., Edwards S., et al. Co-Infusion of matched sibling donor cord blood and bone marrow as stem cell source for allogeneic stem cell transplantation in pediatric non-malignant disorders. Biol Blood Marrow Transplant 2008, 14(2):75-76.
22. Serikov V., Hounshell C., Larkin S., et al. Human term placenta as a source of hematopoietic cells. Exp Biol Med (Maywood) 2009, 234(7):813-823.
23. Jaing T.H., Hung I.J., Yang C.P., et al. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major. Biol Blood Marrow Transplant 2005, 11(5):349-353.
24. Vanichsetakul P., Wacharaprechanont T., O-Charoen R., et al. Umbilical cord blood transplantation in children with beta-thalassemia diseases. J Med Assoc Thai 2004, 87(Suppl 2):S62-S67.
25. Jaing T.H., Yang C.P., Hung I.J., et al. Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia. Bone Marrow Transplant 2007, 40(4):307-311.
26. Jaing T.H., Hung I.J., Yang C.P., et al. Second transplant with two unrelated cord blood units for early graft failure after cord blood transplantation for thalassemia. Pediatr Transplant 2009, 13(6):766-768.
27. Jaing T.H., Tan P., Rosenthal J., et al. Unrelated cord blood transplantation (UCBT) for transfusion-dependent thalassemia-a cibmtr audited retrospective analysis of 51 consecutive patients. Biol Blood Marrow Transplant 2008, 14(2):6-7.
28. Jaing T.H., Chen S.H., Tsai M.H., et al. Transplantation of unrelated donor umbilical cord blood for nonmalignant diseases: a single institution's experience with 45 patients. Biol Blood Marrow Transplant 2010, 16(1):102-107.
29. Allain J.P., Bianco C., Blajchman M.A., et al. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Med Rev 2005, 19(2):110-126.
30. Lin L. Inactivation of cytomegalovirus in platelet concentrates using Helinx technology. Semin Hematol 2001, 38(4 Suppl 11):27-33.
31. McCullough J., Vesole D.H., Benjamin R.J., et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT trial. Blood 2004, 104(5):1534-1541.
32. Snyder E., McCullough J., Slichter S.J., et al. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet a light for pathogen inactivation: the SPRINT trial. Transfusion 2005, 45(12):1864-1875.
33. van Rhenen D., Gulliksson H., Cazenave J.P., et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003, 101(6):2426-2433.
34. Van Voorhis W.C., Barrett L.K., Eastman R.T., et al. Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV. Antimicrob Agents Chemother 2003, 47(2):475-479.
35. Wollowitz S. Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin Hematol 2001, 38(4 Suppl 11):4-11.
36. Jordan C.T., Roback J.D. Separating antiviral and GVHD activities of donor T cells prior to bone marrow transplantation. Immunol Res 2004, 29(1-3):209-218.
37. Kuypers F.A., Watson G., Sage E., et al. Stem cell transplantation with S-59 photochemically treated T-cell add-backs to establish allochimerism in murine thalassemia. Ann N Y Acad Sci 2005, 1054:214-222.
38. Hurley C.K., Fernandez Vina M., Setterholm M. Maximizing optimal hematopoietic stem cell donor selection from registries of unrelated adult volunteers. Tissue Antigens 2003, 61(6):415-424.
39. Querol S., Rubinstein P., Marsh S.G., et al. Cord blood banking: 'providing cord blood banking for a nation'. Br J Haematol 2009, 147(2):227-235.
40. Querol S., Mufti G.J., Marsh S.G., et al. Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?. Haematologica 2009, 94(4):536-541.
41. Jaing T.H., Wang B., Gjertson D., et al. Unrelated cord blood transplantation (UCBT) of 30 consecutive patients with transfusion-dependent thalassemia from a single center. Biol Blood Marrow Transplant 2009, 15(2):24-25.